drugset / Trial / NCT00343135

AUGMENTIN 1gm In Skin And Soft Tissue Infection

NCT00343135

Phase 4 Completed 195 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Study to evaluate the effects of AUGMENTIN 1gm in the treatment of Skin and Soft tissue infections

Timeline

Start
2004-12
Primary completion
2005-03
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 875 mg Oral
Subject clavulanic acid Small molecule 125 mg Oral

Indications